Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US
Glucagon-like peptide 1 receptor agonists and glucagon-like peptide 1/gastric inhibitory polypeptide receptor agonists offer weight reduction and associated health benefits that, if sustained over time, have the potential to markedly improve population health. However, over 40% of US adults have obe...
| 出版年: | Journal of Comparative Effectiveness Research |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Becaris Publishing Limited
2025-01-01
|
| 主題: |